Important Dates

Notices

Table of Contents

• Description
• Objectives
• Eligibility
• Guidelines
• Performance Measurement
• Review Process and Evaluation
• How to Apply
• Contact Information
• Additional Information

Description

The Operating Grant Priority Announcement (Specific Research Areas) competition is a series of strategic initiatives offering additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas or mandates. Applications are submitted through the March 2008 (2008-06) competition of the Operating Grant: 2008-2009 funding opportunity.

The Operating Grant Program is the foundation of CIHR's programming. CIHR recognizes that the creativity, skill, and insight of individuals and self-assembled teams lie at the heart of the research enterprise. The pursuit of excellence in research, as evaluated through the peer review process, inspires ideas that drive progress and ensures a continuous flow of fresh insights.

Funds Available

CIHR's contribution to the amount available for these strategic initiatives is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them.

Funds Available for Research in Specific Areas:
In this competition, additional funds are available to encourage and support applications in specific areas that are aligned with CIHR's research priority areas and mandates. Information on the research areas to be funded as well as the maximum amounts per grant that can be requested is found in the "Objectives" section.

A. CIHR Research Priority Areas:

• Aboriginal Women's Health
• Aging
• Blood Supply Risk
• Blood Utilization and Conservation
• Breast Cancer
• Ethics
• History of Medicine
• HIV/AIDS
• HIV/AIDS (Bridge-Funding)
• Infrastructure and Operating Grants (Leaders Opportunity Fund)
• Knowledge Translation
• Mobility in Aging
• Musculoskeletal Health, Arthritis, Skin and Oral Health (Updated: 2008-07-23)
• Obesity - Prevention and Treatment
• Ovarian Cancer (Bridge Funding) (Updated: 2008-07-23)
• Pandemic Preparedness (Bridge Funding)
• Prevention and Treatment of Illicit Drug Use (Updated: 2008-08-06)
• Regional Partnerships Program - Manitoba
• Regional Partnerships Program - New Brunswick
• Regional Partnerships Program - Newfoundland and Labrador
• Regional Partnerships Program - Nova Scotia
• Regional Partnerships Program - Prince Edward Island
• Regional Partnerships Program - Saskatchewan (Updated: 2008-07-23)
• Reproductive and Child Health (Start-Up Grants for New Investigators)
• Transfusion related acute lung injury (TRALI)

B. Research Related to CIHR Institute Mandates:

• CIHR Institute of Cancer Research (Bridge-Funding)
• CIHR Institute of Gender and Health (Bridge Funding)
• CIHR Institute of Genetics (Bridge-Funding) (Updated: 2008-09-03)
• CIHR Institute of Infection and Immunity (Bridge Funding)
• CIHR Institute of Nutrition, Metabolism and Diabetes (Bridge Funding)

C. Prizes in CIHR Research Priority Areas:

• Huntington (Prize) (Updated: 2008-08-06)
• Maud Menten New Principal Investigator (Prize)

Objectives

The specific objective of the Operating Grant Priority Announcement (Specific Research Areas) is to offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas and mandates.

A. CIHR Research Priority Areas

Aboriginal Women's Health

The CIHR Institute of Aboriginal Peoples' Health (CIHR-IAPH) in partnership with the Ontario Women's Health Council (OWHC), an advisory body to the Ontario Ministry of Health and Long-Term Care, will fund applications that are determined to be relevant¹ to the research priority areas described below:

• Research related to the mandate of CIHR-IAPH² and to cardiovascular disease or mental illness in Ontario Aboriginal women across the lifespan. The research must incorporate traditional Aboriginal approaches to wellness, as well as Western approaches to health, regarding cardiovascular disease or mental illness in Ontario Aboriginal women, in one or more of the following areas: 
• identification of approaches to education, health promotion and prevention;
• identification of methodologies for early identification; or
• identification of treatment and after care.

More information on the research priorities of CIHR-IAPH can be found in their Five-Year Strategic Plan: 2006 to 2011.

The maximum amount awarded for a single grant is $100,000 per annum for up to two years.

Additional Information:

• Specifically, the funding from the Ontario Women's Health Council is for Ontario-based researchers who have expertise in the following areas: Aboriginal health, women's health and cardiovascular or mental health.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Aging

The CIHR Institute of Aging (CIHR-IA) will fund applications that are determined to be relevant to Research on Aging Priority Topics.

The maximum amount awarded for a single grant is up to $100,000 per annum for up to one year, for applications within and across the Institute's priority topics. CIHR-IA anticipates that approximately three grants will be funded through this competition.

Additional Information:

CIHR-IA will evaluate applications for relevance using the following criteria which must be addressed in separate paragraphs within one relevance form (see "How to Apply"):

• Criterion #1: Extent to which the proposal addresses one or more of the five Research on Aging Priority Topics.
• Criterion #2: Extent to which the research and research design address issues of aging and/or the aged as essential elements of the research objectives, hypotheses and analyses (e.g. dynamics of aging, age-relevant models and/or aged subjects; uniqueness of aging or aged population).

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Blood Supply Risk

The CIHR Institute of Circulatory and Respiratory Health, in partnership with Canadian Blood Services (CBS) will fund applications that are determined to be relevant to the research priority areas described below:

• Donor deferral strategies and the risk of transmission of blood bourne diseases.
• Policy development and social aspects of blood system risk.
• Emerging pathogens in specific populations including sexually active gay men.

The goals of the program are to promote and facilitate research in the area of blood supply risk.

CBS is a not-for-profit, charitable organization whose sole mission is to manage the blood and blood products in all provinces outside of Quebec. To this end, CBS:

• Collects approximately 900,000 units of blood annually and processes it into the components and products that are administered to thousands of patients each year.
• Manages the OneMatch Stem Cell and Marrow Network. It is dedicated to recruiting and locating compatible, committed, healthy, unrelated donors for patients in Canada and around the world.
• Screens every donor and tests each unit of blood or blood product collected for a variety of transmissible diseases.
• Ensures that Canadian transfusion medicine research and development remains at the cutting edge.

More information on the research priorities of CIHR-ICRH and Canadian Blood Services (CBS) can be found on their websites.

The maximum amount awarded for a single grant is up to $100,000 per annum for up to three years.

Additional Information:

• Partner will not pay for parental leave but agrees to extend the term of the grant by the duration of the leave.
• The grant is non-renewable.
• The grant must be held in Canada.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Blood Utilization and Conservation

The CIHR Institute of Circulatory and Respiratory Health in partnership with Canadian Blood Services (CBS) will fund applications that are determined to be relevant to the research priority areas described below:

• Blood utilization and conservation.

More information on the research priorities of CIHR-ICRH and Canadian Blood Services (CBS) can be found on their websites.

The maximum amount awarded for a single grant is up to $100,000 per annum for up to three years.

Additional Information:

• Partner will not pay for parental leave but agrees to extend the term of the grant by the duration of the leave.
• The grant is non-renewable.
• The grant must be held in Canada.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Breast Cancer

CIHR, in partnership with the Canadian Breast Cancer Research Alliance (CBCRA)³ will fund applications that are determined to be relevant to the research priority area described below:

• Breast cancer research.

It is the objective of the Alliance to fund a broad spectrum of cancer research in Canada that will have relevance for prevention, early detection, diagnosis, treatment, rehabilitation and palliation for people impacted by breast cancer. Such research could encompass, but is not limited to, fundamental laboratory investigations, clinical trials and epidemiological, psychosocial and behavioural studies and health care research. The ultimate goal is the prevention, cure and eradication of breast cancer. More information on the research priorities of the CBCRA can be found on their website.

Additional Requirements:

• Since applications are adjudicated and administered by CIHR, grantees will be required to submit annual financial reports to CIHR. In addition, because these grants are also considered CBCRA grants, grantees will be required to submit, to the CBCRA office, annual progress reports (to the attention of Dr. Pascale Macgregor, Canadian Breast Cancer Research Alliance, 375 University Avenue, 6th floor, Toronto, ON M5G 2J5), as well as lists of all publications resulting in whole or in part from their CBCRA/CIHR grant. These publications will be included in the CBCRA Research Portfolio. Grantees will also be invited to present their results at CBCRA's Reasons for Hope conferences.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Ethics

The CIHR Ethics Office will fund applications that are determined to be relevant to the research priorities described below:

• Research in ethics related to health, health research and/or health policy.

This funding opportunity is intended to support excellent applications for 1) research projects in ethics on any relevant research questions within the domains of biomedical sciences, clinical sciences, health services and policy, and population and public health; and 2) conceptual and/or empirical research addressing ethical challenges relevant to CIHR's mandate.

Ethics issues associated with health, health research or health policy must be the central focus of the proposed study, and may relate to ethics models, frameworks, concepts, principles or values, and/or the application of these. Scientific, social and legal issues, if addressed, should support the elucidation of the ethical issues.

The maximum amount awarded for a single grant is $50,000 per annum for up to three years. CIHR anticipates that one to three grants will be funded through this competition.

Additional Information:

• In order to maximize the number of applications funded through this initiative, the Ethics Office may invite other CIHR branches or Institutes to consider funding relevant applications that receive a score of 3.5 or above. For this purpose, the anonymized application summary will be shared with CIHR branches or CIHR Institutes at the discretion of the CIHR Ethics Branch, according to the Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP).

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

History of Medicine

The Associated Medical Services (AMS) will contribute additional funds towards grants awarded in the history of medicine, as described below:

• History of medicine, health, health care or disease (broadly defined).

The goals of this collaboration include: to streamline administration of research funding in the history of medicine and health for both organizations; to develop capacity to conduct research in the history of medicine; and to broaden the understanding of how historical evidence can address contemporary health issues (e.g. epidemics like SARS, health care system reforms).

More information on the research priorities of the Associated Medical Services can be found on their website.

The maximum amount awarded for a single grant is up to $25,000 per annum for up to five years. Approximately five grants will be funded through this competition.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

HIV/AIDS

The CIHR Institute of Infection and Immunity - HIV/AIDS Research Initiative will fund applications that are determined to be relevant to the research priority areas described below:

• Health systems, services and policy.
• Resilience, vulnerability and determinants of health.
• Prevention technologies and interventions.
• Drug development, toxicities and resistance.
• Pathogenesis.
• Issues of co-infection.

The CIHR Institute of Infection and Immunity is a partner in the Canadian HIV Vaccine Initiative (CHVI). Under this program, applications which are consistent with the guiding principles of CHVI and are relevant to the defined research areas below will be considered: 

• Basic and social research related to HIV vaccines.

More information on the research priorities of the HIV/AIDS Research Initiative can be found on the Institute of Infection and Immunity website. Research in the priority areas described above that focuses on at risk populations including people living with HIV/AIDS, men who have sex with men, injection drug users, Aboriginal Peoples, prison inmates, youth at risk, women at risk and people from countries where HIV is endemic, is encouraged.

The maximum amount awarded for a single grant is $200,000 per annum for up to three years. CIHR anticipates that seven to ten grants will be funded through this competition. (Updated: 2008-07-10)

Additional Information:

• The primary research focus of the application must be HIV/AIDS.
• Applications to the HIV/AIDS Research Initiative are sought in two distinct funding streams - Biomedical/Clinical Research and Health Services/Population Health Research. Although projects which display a multidisciplinary approach across all four research pillars are strongly encouraged and accepted, applicants must clearly indicate the most relevant funding stream in the relevance field of their ResearchNet application.
• The grant is non-renewable.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

HIV/AIDS (Bridge-Funding).

The CIHR Institute of Infection and Immunity (CIHR-III) is the lead CIHR Institute for the CIHR HIV/AIDS Research Initiative. This initiative, supported by the Federal Initiative to Address HIV/AIDS in Canada, promotes Canadian research and builds capacity in order to increase our understanding of the virus, the epidemic and effective responses.

The HIV/AIDS Research Initiative will offer one year bridge funding for applications that are determined to be relevant to the HIV/AIDS Research Initiative priority areas as described below:

• Health systems, services and policy.
• Resilience, vulnerability and determinants of health.
• Prevention technologies and interventions.
• Drug development, toxicities and resistance.
• Pathogenesis.
• Issues of co-infection.

Further information on the Priorities for the CIHR HIV/AIDS Research Initiative is available on the Institute website.

The maximum amount awarded for a single grant is $100,000 per annum for up to one year. 

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Infrastructure and Operating Grants (Leaders Opportunity Fund)

CIHR, in partnership with the Canada Foundation for Innovation (CFI)⁴, will fund applications that are determined to be relevant⁵ to the research priority area described below:

• Leaders Opportunity Fund.

The objectives of this initiative are: to lessen both applicant and reviewer workload by reducing the number of applications needed to secure both operating and infrastructure support; to create a unique, user-friendly funding tool for researchers and institutions; and to ensure an accurate and fair review of both operating and infrastructure support requests. It is expected that this initiative will allow universities and researchers the opportunity to create streamlined, competitive packages for the funding of infrastructure needs and operational research support.

Additional Information:

• Operating grant requests will be governed by the policies and guidelines for CIHR's Operating Grant Program, as described within the text of this priority announcement.
• Infrastructure requests will be governed by CFI's application deadlines, eligibility, notification dates and grant start dates please refer to the CFI's program guide.
• Applications receiving a rating of less than 3.5 will not be considered for funding.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Knowledge Translation (KT)

CIHR's Knowledge Synthesis and Exchange Branch will fund applications that are determined to be relevant to the research priority areas described below:

• Increasing understanding of the theory and practice of knowledge translation.
• Tools/measures to evaluate effectiveness/impact of knowledge translation practices/interventions.
• Moving research into action (doing knowledge translation).

CIHR's mandate is "to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improve health for Canadian, more effective health services and products and a strengthened Canadian health care system." The purpose of this funding opportunity is to further strengthen knowledge translation (synthesis, dissemination, exchange and ethically sound application of knowledge) by supporting knowledge translation operating grants. It is expected that this targeted investment will lead to a better understanding of concepts, theories and practices that underlie effective KT in order to improve the health for Canadian, provide more effective health services and products and strengthen the health care system.

The maximum amount awarded for a single grant is $100,000 per annum for one year. CIHR anticipates that three grants will be funded through this competition.

Additional Information:

• Partner will not pay for parental leave but agrees to extend the term the award by the duration of the leave.
• The award in non-renewable.

More information on the research priorities of CIHR's Knowledge Synthesis and Exchange Branch can be found on their website.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Mobility in Aging

The CIHR Institute of Aging (CIHR-IA) will fund applications that are determined to be relevant to the Mobility in Aging Initiative.

The maximum amount awarded for a single grant is up to $100,000 per annum for up to three years for applications relevant to the Mobility in Aging Initiative. CIHR-IA anticipates that up to three grants will be funded through this competition.

Additional Information:

CIHR-IA will evaluate applications for relevance using the following criteria which must be addressed in separate paragraphs within one relevance form (see "How to Apply"):

• Criterion #1: Extent to which the proposal addresses eligible areas of inquiry under the Mobility in Aging Initiative.
• Criterion #2: Extent to which the research and research design address issues of aging and/or the aged as essential elements of the research objectives, hypotheses and analyses (e.g. dynamics of aging, age-relevant models and/or aged subjects; uniqueness of aging or aged population).

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

(Updated: 2008-07-23)
Musculoskeletal Health, Arthritis, Skin and Oral Health

The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant⁷ to the research priority areas described below:

• Research priorities of CIHR-IMHA.

More information on the strategic research priorities of CIHR-IMHA can be found on their website.

The maximum amount awarded for a single grant is up to $100,000 per annum for one year. CIHR-IMHA anticipates that up to 4 grants will be funded through this competition. CIHR's contribution to the amount available for these strategic initiatives is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them.

Additional Information:

• At least half of the grants will be allocated to new investigators.⁸ Any additional funding will be allocated to the next top ranked new investigator first, then the next top ranked established investigator.
• Nominated Principal Investigators are eligible to receive only one grant at a time through IMHA's priority announcement program.
• Applicants must indicate IMHA as the primary institute and fill out a priority announcement relevancy form.
• Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator at the time of submission to this program are not eligible for funding from this priority announcement.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Obesity - Prevention and Treatment

The CIHR Institute of Nutrition, Metabolism and Diabetes will fund applications that are determined to be relevant⁶ to the prevention and treatment of obesity as described in the Strategic Initiative Excellence, Innovation and Advancement in the Study of Obesity and Healthy Body Weight, as described below:

• Prevention and treatment of obesity.

Applicants submitting proposals under the strategic initiative can come from any discipline or area of expertise, and can propose research in any number of areas. Applicants must justify how their application contributes to increasing knowledge to prevent or to treat of obesity.

The maximum amount awarded for a single grant is up to $100,000 per annum for one year. CIHR-INMD anticipates that up to two grants will be funded through this competition.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

(Updated: 2008-07-23)
Ovarian Cancer (Bridge-Funding)

The Institute of Cancer Research, in partnership with Ovarian Cancer Canada, will fund applications that are determined to be relevant to the research priority area described below:

• Ovarian cancer.

The goal of the priority announcement is to allow Ovarian Cancer Canada (OCC) to support high quality ovarian cancer research. The Program will consider applications to fund projects in any discipline of research that contributes to the acquisition and application of knowledge in the field of ovarian cancer. They can include, but are not limited to:

• Basic research investigating ovarian biology relevant to ovarian cancer.
• Research directed toward an understanding of the causes, development and progression of ovarian cancer.
• Research that aims to identify novel factors (e.g. genetic, lifestyle, environmental) that contribute to the initiation or progression of ovarian cancer.
• Research that addresses the psychological or social needs of women with ovarian cancer.
• Applied research designed specifically to translate promising research advances from basic research into pre-clinical and clinical investigations relevant to the prevention, early detection or treatment of ovarian cancer.

The Program provides support for research to:

• maintain ovarian cancer research capacity in Canada; and
• allow researchers submitting highly meritorious fundable but not funded ovarian cancer research applications to the CIHR Operating Grants competition, to reapply to subsequent competition without disbanding their research team, and acquiring new research data to strengthen their future application.

Since applications are adjudicated and administered by CIHR and because these grants are also considered OCC grants, grantees will be required to submit, to ICR and to the OCC office, an end of grant summary of the work that has taken place during the tenure of the award (to the attention of Elisabeth Ross at the OCC address below). Grantees will also be encouraged to present at the biennial Canadian Conference on Ovarian Cancer Research.

More information on the research priorities of CIHR-ICR and Ovarian Cancer Canada can be found on their websites.

The maximum amount awarded for a single grant is up to $100,000 for one year. Approximately two grants will be funded through this competition.

Additional Information:

• Partner will not pay for parental leave but agrees to extend the term the award by the duration of the leave.
• The award is non-renewable.
• The award must be held in Canada.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Pandemic Preparedness (Bridge Funding)

The CIHR Institute of Infection and Immunity (CIHR-III) will offer one year bridge funding for applications that are determined to be relevant to the Pandemic Preparedness Strategic Research Initiative as described below:

• Pandemic preparedness and the current pandemic influenza threat.

The maximum amount awarded for a single grant is $100,000 per annum for up to one year.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

(Updated: 2008-08-06)
Prevention and Treatment of Illicit Drug Use

The CIHR Institute of Neurosciences, Mental Health and Addiction will fund applications that are determined to be relevant to the research priority area described below:

• Prevention and Treatment of Illicit Drug Use

The maximum amount awarded for a single grant is up to $100,000 per annum for one year. CIHR-INMHA anticipates that up to 2 grants will be funded through this competition.

Additional Information:

• The substances covered by this initiative are illicit drugs such as marijuana, cocaine, heroin, ecstasy and methamphetamine (crystal meth). Other psychoactive substances such as alcohol, psychotropic pharmaceuticals (over-the-counter and prescription), solvents and inhalants can be studied only if they are used in combination with an illicit drug.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Regional Partnerships Program - Manitoba

CIHR, through the Regional Partnerships Program (RPP), in partnership with the Manitoba Health Research Council may fund applications in Manitoba in all four pillars of research, subject to funding availability.

The maximum amount awarded for a single grant is $100,000 per year for up to 2 years except where $100,000 is not equivalent to 75% or greater of the approved annual budget of an individual grant, then 75% pro-rated budget amount will apply. Approximately 6 grants are expected to be funded (subject to the availability of funds).

Please note researchers must submit their applications at least two weeks prior to the CIHR deadline to have their applications vetted by the internal review procedures at MHRC in order for their grant to be eligible for consideration for RPP funding.

Additional Information:

• The grant is not renewable through the RPP program.
• Recipient will be the top ranked researcher.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Regional Partnerships Program - New Brunswick

CIHR, through the Regional Partnerships Program (RPP), in partnership with the New Brunswick-RPP may fund applications in all four pillars of health research that contribute to the goal of building health research capacity in New Brunswick, which meet RPP eligibility requirements.

More information on the research priorities of New Brunswick can be found on the province's website.

The maximum amount awarded for a single grant is $100,000 per annum for up to 3 years. Approximately 2 grants are expected to be funded (pending availability of funds).

Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures of the New Brunswick RPP Advisory Board a minimum of two weeks prior to submitting their application to CIHR in order for their grant to be eligible for consideration for RPP funding.

Additional Information:

• The grant is not renewable through the RPP program.
• Recipient will be the top ranked researcher.
• The grant must be held in New Brunswick and in accordance with the CIHR-RPP guidelines.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Regional Partnerships Program - Newfoundland and Labrador

CIHR, through the Regional Partnerships Program (RPP), in partnership with Newfoundland and Labrador-RPP may fund applications in all four pillars of health research in NL which meet RPP eligibility requirements.

More information on the research priorities of Newfoundland and Labrador (PDF) can be found on their website.

The maximum amount awarded for a single grant will normally be up to $150,000 per annum for up to three years for new grants, and one year for renewals. Approximately 6 grants are expected to be funded (pending availability of funds).

Please note researchers must submit their applications at least one month prior to the CIHR deadline to have their applications vetted by the internal review procedures at RPP-NL in order for their grant to be eligible for consideration for RPP funding. Contact for this process is:

Office of Research and Graduate Studies
Faculty of Medicine
Memorial University
St. John's NL

Additional Information:

• The grant is non-renewable under the RPP program.
• The grant must be held in NL and in accordance with the CIHR-RPP guidelines.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Regional Partnerships Program - Nova Scotia

CIHR, through the Regional Partnerships Program (RPP), in partnership with the Nova Scotia Health Research Foundation (NSHRF) may fund applications in all four pillars of health research in Nova Scotia pending funding availability, which meet RPP eligibility requirements.

New grants are awarded for up to three years. The maximum amount awarded for a renewal grant is $70,000 for one year. Approximately 4 to 8 grants (new and renewal) are expected to be funded (pending availability of funds).

Please note that in order to be considered for RPP funding, researchers must submit their applications to NSHRF within 10 business days of the CIHR deadline in order for their grant to be eligible for consideration for RPP funding.

Additional Information:

• The grant is non-renewable under the RPP program.
• The grant must be held in Nova Scotia and in accordance with the CIHR-RPP guidelines.
• Recipient will be the top ranked researcher.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Regional Partnerships Program - Prince Edward Island

CIHR, through the Regional Partnerships Program (RPP), in partnership with Prince Edward Island-RPP may fund applications that span the four pillars of research that contribute to the goal of building health research capacity in PEI. The following areas of research strength at UPEI reflect these four pillars:

• Cardiovascular and respiratory health research.
• Metabolism, nutrition and diabetes.
• Human development and cognition.
• Cancer research.
• Applied health services and health promotion.
• Natural products and human health.
• Population health.

More information on the research priorities of Prince Edward Island can be found in the University of Prince Edward Island Strategic Plan (PDF).

The maximum amount awarded for a single grant is up to $100,000 per annum for up to 3 years. However, the amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available. Approximately 2 grants are expected to be funded (pending availability of funds).

Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures at the PEI Health Research Institute a minimum of two months prior to submitting their application to CIHR in order for their grant to be eligible for consideration for RPP funding.

Additional Information:

• The grant is non-renewable under the RPP program.
• The grant must be held in Prince Edward Island.
• Recipient will be the top ranked researcher.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

(Updated: 2008-07-23)
Regional Partnerships Program - Saskatchewan

CIHR, through the Regional Partnerships Program (RPP), in partnership with Saskatchewan-RPP may fund highly rated applications in Saskatchewan, subject to funding availability.

Operating grants from all four pillars of research will be supported based upon the ratings that they received. However, half of the available funding will be awarded based upon the following listed research priority areas:

• Health needs of Aboriginal people and Seniors.
• Health systems and policy research, with emphasis on: health human resources and workforce planning; quality management and improvement; primary health care; mental health and addictions; innovative delivery models; and rural and remote health services.
• Determinants of health status, including early childhood development and the prevention and underlying causes of chronic and lifestyle-related disease (particularly diabetes, obesity and smoking).
• Public health including infectious diseases and water and food safety.
• Synchrotron-based health research.

More information on Saskatchewan's research priorities can be found in the Health Research Strategy (PDF).

The grant amount will be as recommended by CIHR; the duration will be for two years, unless a shorter period is recommended by CIHR.

Please note that researchers must have their CIHR applications vetted by the internal review procedures at their University or institution prior to submitting to CIHR in order for their grant to be eligible for consideration for RPP funding:

• University of Saskatchewan - 4 weeks prior to CIHR deadline.
• University of Regina- 4 weeks prior to CIHR deadline.

Please contact the Research Offices at the University of Saskatchewan and the University of Regina for more information:

Research Services
University of Saskatchewan
Box 5000 RPO University
Saskatoon, SK, S7N 4J8
Telephone: (306) 966-8576
Fax: (306) 966-8597
E-mail: research.services@usask.ca

Office of Research Services
University of Regina
3737 Wascana Parkway
Regina, SK, S4S 0A2
Telephone: (306) 585-4775
Fax: (306) 585-4893
E-mail: research.services@uregina.ca

To be considered for the Saskatchewan priority areas (see above) researchers must provide a copy of the summary page of their application and a one-page statement justifying the fit of the application with at least one priority area. Researchers will contacted by the Office of the Associate Vice-President Research (Health) shortly after the application deadline to provide this information.

Additional Information:

• The grant is non-renewable for the first re-application following RPP funding.
• The grant must be held in a Saskatchewan institution by a Saskatchewan researcher; for eligibility guidelines, see the Saskatchewan - CIHR RPP Policies.
• Recipient will be the top ranked researchers after consideration of the requirements above.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Reproductive and Child Health (Start-Up Grants for New Investigators)

The CIHR Institute of Human Development, Child and Youth Health (CIHR-IHDCYH) will fund applications that are determined to be relevant to the research priority areas, as indicated below:

• Research priority areas of CIHR-IHDCYH.

The objective of this priority announcement is to further strengthen research that relates to the Strategic Research Priorities of the CIHR-IHDCYH by increasing research capacity. It is expected that this targeted investment will lead to increased success rates for new Principal Investigators in future CIHR regular open competitions.

The maximum amount awarded for a single grant is $100,000 per annum for up to one year. CIHR-IHDCYH anticipates that approximately three grants will be funded through this competition.

Additional Requirements:

• Grants are offered only to investigators with less than six years of experience as independent investigators since their first academic appointment (i.e. after September 2002, including experience outside Canada) and who have never held a CIHR grant as a Principal Investigator (including the SickKids Foundation (SKF)/IHDCYH New Investigators Grants Program).

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Transfusion Related Acute Lung Injury (TRALI)

The CIHR Institute of Circulatory and Respiratory Health in partnership with Canadian Blood Services (CBS) will fund applications that are determined to be relevant to the research priority areas described below:

• Transfusion related acute lung injury (TRALI).

Research projects may focus on any relevant research question within biomedical, clinical, or health policy research. Examples of relevant questions include defining the scope of TRALI, mechanisms of induction of TRALI in both animals models and patient populations, identification of pathogenic antibodies, identification of best testing methods, studies to inform donor deferral policy making, identification of factors (including genetic factors) that increase a recipient's susceptibility to TRALI, and epidemiology studies to establish the incidence of TRALI.

More information on the research priorities of CIHR-ICRH and Canadian Blood Services (CBS) can be found on their websites.

The maximum amount awarded for a single grant is up to $100,000 per annum for up to three years.

Additional Information:

• Partner will not pay for parental leave but agrees to extend the term of the grant by the duration of the leave.
• The grant is non-renewable.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

B. Research Related to CIHR Institute Mandates

The following CIHR Institutes are offering priority announcements for research related to their mandates. The maximum amount awarded for a single grant is $100,000 per annum for up to one year. 

CIHR Institute of Cancer Research (Bridge Funding)

The objective of the CIHR Institute of Cancer Research One-Year Bridging Operating Grants is to ensure the maintenance of excellent research programs. These one-year operating grants afford principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees. (Updated: 2008-07-02)

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

CIHR Institute of Gender and Health (Bridge Funding)

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

CIHR Institute of Genetics (Bridge Funding)

The objective of the CIHR Institute of Genetics (IG) Bridging Operating Grants is to ensure the maintenance of excellent research programs aligned with the mandate of the IG. These one-year operating grants afford principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees.

The maximum amount awarded will be $100,000 per grant for a term of one year and will not include equipment. Applications receiving a rating of less than 4.0 will not be considered for funding. (Updated: 2008-09-03)

Additional Information (Updated: 2008-08-13)

• The IG must be identified as the primary or secondary Institute affiliation the "Suggested CIHR Institute" section of their operating grant application; and
• Research proposals must fall within the IG’s mandate

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

CIHR Institute of Infection and Immunity (Bridge Funding)

The CIHR Institute of Infection and Immunity (CIHR-III) will offer one year bridge funding for applications that are determined to be relevant to the Institute's mandate. The maximum amount awarded for a single grant is $100,000 per annum for up to one year.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

CIHR Institute of Nutrition, Metabolism and Diabetes (Bridge Funding)

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

C. Prizes in CIHR Research Priority Areas:

(Updated: 2008-08-06)
Huntington (Prize)

CIHR in partnership with the Huntington Society of Canada (HSC) and the CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) will fund applications that are determined to be relevant to the research priority areas described below.

• Basic biomedical research on Huntington's Disease

More information on the research priorities of the Huntington Society of Canada and CIHR-INMHA be found on their websites.

The maximum amount awarded for a single grant is for $15,000 per annum for up to one year. CIHR anticipates that one grant will be funded through this competition.

Funding from HSC will be in the form of a top up to an operating grant from the September 2008 or March 2009 CIHR Open Operating Grant competitions. The recipient, identified as the top-ranked basic biomedical researcher in the area of Huntington's Disease, will receive $15,000 in the first year of the grant.

Additional Information:

• See the section "Review Process and Evaluation Criteria - Relevance Review" for information about the relevance review process specific to Prizes in CIHR Research Priority Areas.
• Applications to the regular Operating Grant competitions will be entered automatically into priority announcement prize competitions. Consideration for funding through priority announcement prizes is in addition to consideration for other types of priority announcement funding.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Maud Menten New Principal Investigator (Prize).

The Institute of Genetics (IG) Maud Menten New Investigator Prizes consist of a one-year, non-renewable $30,000 research grant. One prize in each of the following research areas is available: i) biomedical; ii) clinical; and iii) health services/population health, including genetic ethical, legal and social issues. For each research area, the IG also makes available two finalist prizes. Finalist prizes consist of a one-year, non-renewable $1,000 research grant.

Specific Eligibility Requirements:

All Nominated Principal Investigators who meet the following criteria will be considered for the 2009 IG Maud Menten New Principal Investigator Prizes:

• successful in either the September 2008 or March 2009 CIHR Operating Grants competition with a rating of 4.0 or greater;
• identified the IG as their primary or secondary Institute affiliation the "Suggested CIHR Institute" section of their operating grant application (page 7 of the printed Research Module); and
• held a full-time appointment as an independent investigator, while actively engaged in CIHR research, including research performed in non-academic setting (e.g. industry, government) for a period of less than 60 months before the competition deadline associated with their successful operating grant application (i.e. September 15 for the 2008 competition and March 1 for the 2009 competition).

The New Principal Investigator with the highest ranked CIHR Operating Grant application - from the combined results of the September 2008 and March 2009 CIHR Operating Grants Competitions - in each research area will be the recipient of one of the three prizes. For each research area, two finalist prizes are also available and will be selected in rank order.

For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.

Eligibility

Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.

Eligibility requirements specific to the Operating Grant Program include the following:

• Only applicants who meet the definition of Principal Applicant, as described in the CIHR Grants and Awards Guide, may submit an application to the Operating Grant Program.
• There is no limit to the number of applications an applicant can submit as a Principal Applicant, whether he/she is the Nominated Principal Applicant or a Co-Principal Applicant, to each Operating Grant competition.
• Applicants to the Operating Grant Program may request that their application be considered for:
• Up to three Priority Announcements per application, in each Operating Grant competition;
• Any number of additional Priority Announcements for research related to a CIHR Institute's mandate, Linked Programs, for example, the Regional Partnerships Program, the Neuromuscular Research Program (Spring competitions only), and the CIHR-Arthritis Society Partnership Program.
• Randomized controlled trials are not funded through this program. For applications including randomized controlled trials, researchers must apply through the Randomized Controlled Trials Program: 2008-2009 and not through the Operating Grant Program.

Guidelines

Applications funded through the Operating Grant Priority Announcement (Specific Research Areas) competition are subject to funding policies outlined in the CIHR Grants and Awards Guide. Guidelines governing CIHR's grant programs are outlined in Section 3: General Guidelines for Grant Programs. Applicants are encouraged to demonstrate the use of Gender and Sex-Based Analysis in applications.

Allowable Costs

Applicants should review the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Financial Administration Guide for a complete listing and description of allowable costs and activities.

The full application must provide a detailed justification of all costs.

Conditions of Funding

All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through the Operating Grant Program. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official Languages Policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR's Support. Successful applicants will be informed of any special financial requirements prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.

Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)

All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.

CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this funding opportunity and all matters pertaining thereto.

While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Funding opportunity will be collected, used and disclosed in compliance with the PIPEDA.

Policy on Access to Research Outputs

CIHR believes that greater access to research publications and data will promote the ability of researchers and knowledge users in Canada and abroad to use and build on the knowledge needed to address significant health challenges. Open access will promote accessibility to CIHR-funded research and will serve to increase the international visibility of Canadian research. As of January 1, 2008, CIHR grant recipients are reminded to adhere with the responsibilities outlined in the Policy on Access to Research Outputs. Under this policy, grant recipients must make every effort to ensure that research papers and bio-molecular data generated from CIHR funding are freely accessible online.

Communication Requirements

Grant recipients are required to acknowledge CIHR, its institutes and partners in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Public Communication and Acknowledgement of CIHR's Support for details on CIHR's communication requirements. The contributing institutes / partners will be identified on the Authorization for Funding and decision letter.

Performance Measurement

CIHR is committed to demonstrating results to Canadians for the money invested in health research. Therefore, processes for monitoring progress and appropriate use of funds, as well as for performance measurement and program evaluation are in place. As a result, funding recipients must:

• adhere to CIHR's reporting requirements and provide required information in a timely fashion. A Progress Report for Long-Term Grant Holders (5 or more years) will be required in year 3 of grants of duration of 5 years or more. Grantees are required to submit the Progress Report for Long-Term Grant Holders (5 or more years) describing the progress made and the publications issued since the start of the grant. CIHR will cancel the last 12 months of the grant if the progress is unacceptable and will cancel the final two years of the grant if it does not receive a report. The "Progress Report for Long-Term Grant Holders (5 or more years)" can be found under List of Forms and Guidelines for Completion;
• contribute to the monitoring, review and evaluation of CIHR's programs, policies and processes by participating in evaluation studies, surveys, workshops, audits and providing data or reports as required for the purpose of collecting information to assess progress and results;
• encourage their associates, trainees and administration to participate in the monitoring, review and evaluation of CIHR's programs, policies and processes as required.

Review Process and Evaluation

Relevance Review

A. CIHR Research Priority Areas:

CIHR and partner organizations will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described under "CIHR Research Priority Areas" within the "Objectives" section.

Relevance of the applications to the research priorities will be determined in the following manner.

Prior to peer review, CIHR and the partner organizations will review applications to determine the relevance, or alignment, of the research proposed to the research priority area(s) described above.

To conduct relevance review, these representatives will have access to a completed relevance form in addition to anonymized project titles and summaries, provided that applicants have consented to the sharing of information in consideration for other funding opportunities as well as to the sharing of information to observers in completing their ResearchNet application.

Upon completion of peer review, the CIHR and the partner organizations will receive the ratings, rankings and peer review committee recommendations on funding level and grant or award term for those applications that 1) are found to be relevant to the specific objectives of the research initiative and the research priority areas described under "CIHR Research Priority Areas"; and 2) are rated within the CIHR fundable range but are not funded through the CIHR Operating Grant: 2008-2009 competition to which they were submitted. These applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a score below 3.5 will not be funded.

B. Research Related to CIHR Institute Mandates:

Upon completion of peer review, representatives of each CIHR Institute will receive a randomized list of applications for which the Institute was selected as primary (and where indicated, secondary) Institute under "Suggested Institutes" on the "Project Descriptors" page of the ResearchNet application. The randomized list will include anonymized titles, project summaries and peer review committee recommendations on funding levels. Eligible applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a rating below 3.5 will not be funded.

C. Prizes in CIHR Research Priority Areas:

Upon completion of peer review, representatives of CIHR and/or partner organizations will receive an anonymized ranking list, funding level and peer review committee recommendations on grant term for all applications 1) that are funded in the regular CIHR Operating Grant competition(s); and 2) that are identified as relevant through a keyword search. This information will be used to conduct relevance review when required and to determine the recipient(s) of the prize(s). These applications will be selected from the top down in order of ranking as far as budgets will allow. Applications that receive a rating below the regular CIHR Operating Grant competition cut-off will not be considered for prizes.

Peer Review

A CIHR peer review committee will evaluate the full applications. Committee members are selected following CIHR's Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP). For information on CIHR's peer review process in general, see the Peer Review section of CIHR's website.

Peer review committees will not be informed of which applications in the Operating Grant: 2008-2009 competition are submitted for funding consideration through the Operating Grant Priority Announcement (Specific Research Areas) competition. .

Evaluation Criteria

Peer review will be conducted in accordance with The CIHR Peer Review Process - Policies and Responsibilities of Grants Committee Members, including the standard evaluation criteria described under "Factors in the Assessment" (section 6.2).

Applications to the CIHR Operating Grant Program are reviewed by one of approximately 50 peer review committees specifically constituted to support the CIHR Operating Grant Program. Each committee consists of about 10-16 members, including a Chairperson and Scientific Officer. For a list of these committees and their respective mandates, refer to Peer Review Committees and Mandates on the CIHR website.

How to Apply

Note: This funding opportunity requires the use of ResearchNet to apply for funding.

• A step-by-step overview of CIHR's application processes can be found under How to Apply for Funding.
• The application process for this funding opportunity is comprised of two steps: Registration and Application.
• Both Registration and Application are submitted through the September 2008 "2008(09)" competition of the Operating Grant: 2008-2009 funding opportunity.
• To complete your Application, review the Operating Grant: 2008-2009 funding opportunity and then follow the specific application guidelines and instructions which are fully described in its "How to Apply" section.
• Reminder to applicants: Please ensure that your application is complete (including all required signatures) and submitted on time to CIHR. Effective September 1, 2008, CIHR will assume no responsibility in following-up with applicants who submit an incomplete application. Incomplete or late applications will not be accepted into the competition.

Additional instructions that must be followed for this funding opportunity.

A. CIHR Research Priority Areas:

• Priority announcements for research in specific CIHR priority areas are listed in the "Objectives" section of this funding opportunity, under "CIHR Research Priority Areas."
• To apply for funding through these priority announcements, select the priority announcement title and relevant research area(s) addressed by your research proposal in the "Identify Priority Announcements and Relevant Research Area" section of your ResearchNet application.
• You may request that your application be considered for up to three priority announcement research areas per application, in each Operating Grant competition.

B. Research Related to CIHR Institute Mandates:

• Priority announcements for research related to CIHR Institute mandates (including bridge funding priority announcements) are listed in the "Objectives" section of this funding opportunity, under "Research Related to CIHR Institute Mandates."
• When you select a CIHR Institute as a primary (and where indicated, secondary) Institute under "Suggested Institutes" on the "Project Descriptors" page of your ResearchNet application, the Institute will automatically consider your application for funding through the priority announcement process whenever it offers a priority announcement for research related to its mandate. Consideration for funding through CIHR Institute mandate priority announcements is in addition to consideration for priority announcement funding in specific research priority areas.

C. Prizes in CIHR Research Priority Areas:

• Priority Announcement prizes are listed in the "Objectives" section of this funding opportunity.
• Your application will automatically be entered into Priority Announcement prize competitions. Refer to the "Review Process and Evaluation Criteria" section above for further details. Consideration for funding through priority announcements prizes is in addition to consideration for priority announcement funding in specific research priority areas.

Contact Information

For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

CIHR Info Desk Service
Canadian Institutes of Health Research
Telephone: 613-954-1968
Toll-free: 1-888-603-4178 
Email: info@cihr-irsc.gc.ca

Specific information about the Operating Grant Program peer review committees can also be obtained by contacting the individuals listed on the CIHR Committees and Programs Contacts page of the CIHR website.

If you are experiencing technical difficulties with your ResearchNet account or the e-Submission process contact:

CIHR ResearchNet Support
Canadian Institutes of Health Research
Telephone: 613-941-9080
Email: support@researchnet-recherchenet.ca

Additional Information

Appendix 1: Contacts for questions about specific priority announcements and their research objectives.

Aboriginal Women's Health

For questions about this initiative and research objectives contact:

Cynthia Stirbys
Assistant Director, CIHR Institute of Aboriginal Peoples' Health
Canadian Institutes of Health Research
Telephone: 613-946-6495
Fax: 613-954-1800
Email: cynthia.stirbys@cihr-irsc.gc.ca

Aging

For questions about this initiative and research objectives contact:

Sharon Nadeau
Associate, Strategic Initiatives, CIHR Institute of Aging
Canadian Institutes of Health Research
Telephone: 613-946-1270
Fax: 613-954-1800
Email: sharon.nadeau@cihr-irsc.gc.ca

Blood Supply Risk

For questions about this initiative and research objectives contact:

Katherine Gardner
Project Manager, CIHR Institute of Circulatory and Respiratory Health
Canadian Institutes of Health Research
Telephone: 613-941-0086
Fax: 613-954-1800
Email: katherine.gardner@cihr-irsc.gc.ca

Blood Utilization and Conservation

For questions about this initiative and research objectives contact:

Katherine Gardner
Project Manager, CIHR Institute of Circulatory and Respiratory Health
Canadian Institutes of Health Research
Telephone: 613-941-0086
Fax: 613-954-1800
Email: katherine.gardner@cihr-irsc.gc.ca

Breast Cancer

For questions about this initiative and research objectives contact:

Dr. Pascale Macgregor
Research Program Director
Canadian Breast Cancer Research Alliance
375 University Avenue, 6th floor
Toronto ON M5G 2J5

Ethics

For questions about this initiative and research objectives contact:

Lynne Cayer
Ethics Office
Canadian Institutes of Health Research
Telephone: 613-952-4264
Fax: 613-954-1800
Email: lynne.cayer@cihr-irsc.gc.ca

History of Medicine

For questions about this initiative and research objectives contact:

Anne-Marie Rollin
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: 613-957-8641
Fax: 613-954-1800
Email: anne-marie.rollin@cihr-irsc.gc.ca

HIV/AIDS

For questions about this initiative and research objectives contact:

Jennifer Ralph, Program Officer
HIV/AIDS Research Initiative
Canadian Institutes of Health Research
Telephone: 613-941-4464
Fax: 613-954-1800
Email: jennifer.ralph@cihr-irsc.gc.ca

HIV/AIDS (Bridge-Funding)

For questions about this initiative and research objectives contact:

Jennifer Ralph, Program Officer
HIV/AIDS Research Initiative
Canadian Institutes of Health Research
Telephone: 613-941-4464
Fax: 613-954-1800
Email: jennifer.ralph@cihr-irsc.gc.ca

Infrastructure and Operating Grants (Leaders Opportunity Fund)

For questions related to specific CFI competitions and programs, including CFI funding guidelines and how to apply contact:

Mark Lagacé
Manager, Leaders Opportunity Fund
Canada Foundation for Innovation
Telephone: 613-996-3107
Fax: 613-943-0923
Email: mark.lagace@innovation.ca

Knowledge Translation

For questions about this initiative and research objectives contact:

Leah Jurkovic
Senior KSE Specialist, Knowledge Synthesis and Exchange branch
Canadian Institutes of Health Research
Telephone: 613-941-0805
Fax: 613-954-1800
Email: leah.jurkovic@cihr-irsc.gc.ca

Mobility in Aging

For questions about this initiative and research objectives contact:

Sharon Nadeau
Associate - Strategic Initiatives, CIHR Institute of Aging
Canadian Institutes of Health Research
Telephone: 613-946-1270
Fax: 613-954-1800
Email: sharon.nadeau@cihr-irsc.gc.ca

Musculoskeletal Health, Arthritis, Skin and Oral Health (Updated: 2008-07-23)

For questions about this initiative and research objectives contact:

Alita Perry
Institute of Musculoskeletal Health and Arthritis
Canadian Institutes of Health Research
Telephone: 613-954-3469
Fax: 613-954-1800
E-mail: alita.perry@cihr-irsc.gc.ca

Obesity - Prevention and Treatment

For questions about this initiative and research objectives contact:

Paul Bélanger
Assistant Director - Ottawa, CIHR Institute of Nutrition, Metabolism and Diabetes
Canadian Institutes of Health Research
Telephone: 613-941-6464
Fax: 613-954-1800
Email: paul.belanger@cihr-irsc.gc.ca

Ovarian Cancer (Bridge Funding) (Updated: 2008-07-23)

For questions about this initiative and research objectives contact:

David Hartell
Associate, Institute Strategic Initiatives, Institute of Cancer Research
Telephone: 613-941-4329
Fax: 613-954-1800
E-mail: david.hartell@cihr-irsc.gc.ca

Elisabeth Ross
Chief Executive Officer, Ovarian Cancer Canada
Telephone: 416-962-2700
Fax: 416-962-2701
E-mail: eross@ovariancanada.org

Pandemic Preparedness (Bridge Funding)

For questions about this initiative and research objectives contact:

Carol Richardson
Manager, Programs and Evaluation, CIHR Institute of Infection and Immunity
Canadian Institutes of Health Research
Telephone: 519-661-3228
Fax: 519-661-4226
Email: carol.richardson@schulich.uwo.ca

Prevention and Treatment of Illicit Drug Use. (Updated: 2008-08-06)

For questions about this initiative and research objectives contact:

Richard Brière
Assistant Director
Institute of Neurosciences, Mental Health and Addiction
Douglas Mental Health University Institute
6875 Lasalle Blvd
Verdun (Québec) H4H 1R3
Telephone: 514-761-6131 ext. 3930
Fax: 514-888-4060
Email: Richard.briere@douglas.mcgill.ca

Regional Partnerships Program - Manitoba

For additional information on eligibility criteria and funding details, please contact:

Shannon Rogalski
Manager, Funding Programs
Manitoba Health Research Council
Phone: 204-783-4249
Email: shannon.rogalski@mhrc.mb.ca
Website: www.mhrc.mb.ca

For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

Jacqueline Jorge
Program Delivery Officer, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON, K1A 0W9
Telephone: 613-952-5728
Email: jacqueline.jorge@cihr-irsc.gc.ca

For questions about this initiative and research objectives contact:

Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca

Regional Partnerships Program - New Brunswick

For questions about the NB RPP Advisory Board review process and criteria, please contact:

John Boyne
Administrator, Medical Research Fund of New Brunswick
P.O. Box 5100
520 King Street
Fredericton, NB, E3B 5G8
Telephone: 506 444-3222
Fax: 506 453-2958
Email: john.boyne@gnb.ca

For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

Jacqueline Jorge
Program Delivery Officer , Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON, K1A 0W9
Telephone: 613-952-5728
Email: jacqueline.jorge@cihr-irsc.gc.ca

For questions about this initiative and research objectives contact:

Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca

Regional Partnerships Program - Newfoundland and Labrador

For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

Jacqueline Jorge
Program Delivery Officer, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON, K1A 0W9
Telephone: 613-952-5728
Email: jacqueline.jorge@cihr-irsc.gc.ca

For questions about this initiative and research objectives contact:

Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca

Regional Partnerships Program - Nova Scotia

Contact for this program is:

Jennifer McNutt,
Manager, Health Research & Matching Grants Programs,
Nova Scotia Health Research Foundation
Telephone: 902-424-3370
Fax: 902-424-7753
Email: mcnuttjs@gov.ns.ca

For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

Jacqueline Jorge
Program Delivery Officer, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON, K1A 0W9
Telephone: 613-952-5728
Email: jacqueline.jorge@cihr-irsc.gc.ca

For questions about this initiative and research objectives contact:

Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca

Regional Partnerships Program - Prince Edward Island

Please contact the following for additional information:

Colleen MacQuarrie
Acting Director Programs & Partnerships
PEI Health Research Institute
University of Prince Edward Island
550 University Avenue
Charlottetown, PE, C1A 4P3
Telephone: 902-894-2812
Fax: 902-628-4359
Email: peihri@upei.ca

For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

Jacqueline Jorge
Program Delivery Officer, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON, K1A 0W9
Telephone: 613-952-5728
Email: jacqueline.jorge@cihr-irsc.gc.ca

For questions about this initiative and research objectives contact:

Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca

Regional Partnerships Program - Saskatchewan

For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

Jacqueline Jorge
Program Delivery Officer, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON, K1A 0W9
Telephone: 613-952-5728
Email: jacqueline.jorge@cihr-irsc.gc.ca

For questions about this initiative and research objectives contact:

Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca

Reproductive and Child Health (Start-Up Grants for New Investigators)

For questions about this initiative and research objectives contact:

Anne-Cécile Desfaits, PhD,
Assistant Director, CIHR Institute of Human Development, Child and Youth Health
Canadian Institutes of Health Research
Telephone: 514-412-4414
Fax: 514-412-4253
Email: anne-cecile.desfaits@cihr-irsc.gc.ca

Transfusion related acute lung injury (TRALI)

For questions about this initiative and research objectives contact:

Katherine Gardner
Project Manager, CIHR-Institute of Circulatory and Respiratory Health
Canadian Institutes of Health Research
Telephone: 613-941-0086
Fax: 613-954-1800
Email: katherine.gardner@cihr-irsc.gc.ca

CIHR Institute of Cancer Research (Bridge-Funding)

For questions about this initiative and the mandate of CIHR-ICR contact:

Benoît Lussier
Assistant Director, CIHR Institute of Cancer Research
Canadian Institutes of Health Research
Telephone: 514-398-4964
Fax: 514-398-8845
Email: benoit.lussier@mcgill.ca

CIHR Institute of Gender and Health (Bridge Funding)

For questions about this initiative and the mandate of CIHR-IGH contact:

Louise Robert
Associate Director, CIHR Institute of Gender and Health
Canadian Institutes of Health Research
Telephone: 613- 954-0616
Fax: 613- 954-1800
Email: louise.robert@cihr-irsc.gc.ca

CIHR Institute of Genetics (Bridge-Funding)

For questions about this initiative and the mandate of CIHR-IG contact:

Jennifer Ahlgren
Institute Project Officer, CIHR Institute of Genetics
Canadian Institutes of Health Research 
Telephone: 613-957-6126 
Fax: 613-954-1800 
Email: jennifer.ahlgren@cihr-irsc.gc.ca

CIHR Institute of Infection and Immunity (Bridge Funding)

For questions about this initiative and the mandate of CIHR-III contact:

Bruce Moor,
Assistant Director, CIHR Institute of Infection and Immunity
Canadian Institutes of Health Research
Telephone: 519-661-3228
Fax: 519-661-4226
Email: bmoor@uwo.ca

CIHR Institute of Nutrition, Metabolism and Diabetes (Bridge Funding)

For questions about this initiative and research objectives contact:

Paul Bélanger
Assistant Director - Ottawa, CIHR Institute of Nutrition, Metabolism and Diabetes
Canadian Institutes of Health Research
Telephone: 613-941-6464
Fax: 613-954-1800
Email: paul.belanger@cihr-irsc.gc.ca

Huntington (Prize) (Updated: 2008-08-06)

For questions about this initiative and research objectives contact:

Don Lamont
Huntington Society of Canada
151 Frederick Street, Suite 400
Kitchener, Ontario N2H 2M2
Telephone: 519-749-8491 ex. 24
E-mail : dlamont@huntingtonsociety.ca

Maud Menten New Principal Investigator (Prize)

For questions about this initiative and research objectives contact:

Jennifer Ahlgren
Project Officer, CIHR Institute of Genetics
Canadian Institutes of Health Research
Telephone: 613-957-6126
Fax: 613-954-1800
Email: jennifer.ahlgren@cihr-irsc.gc.ca

1. Aboriginal Women's Health. The following criteria will be used in conducting the relevance review:

• Alignment of the proposed research with research priority areas for this funding opportunity: cardiovascular disease and/or mental illness in Aboriginal women in Ontario.
• Proposals must identify the incorporation of traditional Aboriginal approaches to wellness and western approaches to health, in one, or more of the following areas: identification of approaches to education, health promotion, prevention, treatment and after care; identification of methodologies for early identification of cardiovascular disease and/or mental illness.
• Proposals must demonstrate knowledge translation with Aboriginal community/communities, and decision-makers working one or more of the following areas: health promotion, chronic disease prevention and management, mental health services.
• Proposed research must demonstrate the involvement of Ontario Aboriginal community-based organizations at all stages of the research process. Research projects funded through this opportunity must also provide financial support to Ontario Aboriginal community-based organization(s).

2. Aboriginal Women's Health. The mandate of the CIHR Institute of Aboriginal Peoples' Health is to support health research that addresses the special health needs of Aboriginal peoples in Canada, and aims to improve the health of First Nations, Inuit and Métis peoples through the assertion of Aboriginal understandings of health and by fostering innovative community-based and scientifically excellent research.

3. Breast Cancer. The Canadian Institutes of Health Research, together with the National Cancer Institute of Canada (NCIC), Health Canada, the Canadian Cancer Society, the Avon Flame Foundation (formerly the Breast Cancer International Centre), the Canadian Breast Cancer Network and the Canadian Breast Cancer Foundation are funding partners in the Canadian Breast Cancer Research Alliance (CBCRA).

4. Infrastructure and Operating Grants (Leaders Opportunity Fund). The Canada Foundation for Innovation (CFI) is an independent corporation created by the Government of Canada to fund research infrastructure. The CFI's mandate is to strengthen the capacity of Canadian universities, colleges, research hospitals, and non-profit research institutions to carry out world-class research and technology development that benefits Canadians.

5. Infrastructure and Operating Grants (Leaders Opportunity Fund). The following criteria will be used in conducting the review of the CFI infrastructure request:

1. Quality of the research and need for the infrastructure
2. Contribution to strengthening the capacity for innovation
3. Potential benefits to Canada

6. Obesity - Prevention and Treatment.

• Research on the prevention of obesity includes studies aimed at the development, implementation and evaluation of strategies for the prevention of overweight/obesity and maintenance of healthy body weight; studies aimed at enhancing knowledge transfer to improve prevention efforts
• Research on the treatment of obesity refers to the development, implementation ad evaluation of strategies for the treatment of overweight/obesity; research focussed on treating obesity related co-morbidities in obese or overweight people; studies aimed at enhancing knowledge transfer to improve treatment efforts

7. Musculoskeletal Health, Arthritis, Skin and Oral Health. The extent to which the relevance form addresses at least one of CIHR-IMHA's three research priorities listed above. A Yes/No score is given.

8. Musculoskeletal Health, Arthritis, Skin and Oral Health. A new investigator is defined as a researcher who has completed all formal training, but with 5 years or less experience as an independent investigator. One does NOT need a new investigator salary award to be classified as a new investigator.